文献速递呼吸衰竭与机械通气儿科与产科急症

极早产儿表面活性物质给药前肺复张:一项随机临床试验的2年随访

Lung Recruitment Before Surfactant Administration in Extremely Preterm Neonates: 2-Year Follow-Up of a Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2024-09-03
一句话结论极早产儿IN-REC-SUR-E与IN-SUR-E在矫正年龄2岁时死亡或严重残疾无显著差异(20.3% vs 13.7%,P=0.36)。

本研究为多中心随机临床试验的随访研究,纳入2015至2018年意大利35个三级新生儿重症监护病房中胎龄24 0/7至27 6/7周、生后24小时内达到持续气道正压通气失败标准的极早产儿,随机1:1接受IN-REC-SUR-E或IN-SUR-E并随访至矫正年龄2岁。共137例完成随访(IN-SUR-E组64例,IN-REC-SUR-E组73例)。矫正年龄2岁时,出院后死亡或严重残疾发生率两组无显著差异(IN-SUR-E组13例[20.3%] vs IN-REC-SUR-E组10例[13.7%],P=0.36);残疾、脑瘫、认知障碍、体格测量指标、反复呼吸道感染及因呼吸原因住院的发生率两组均无显著差异。作者认为这些发现可帮助临床医生在考虑长期结局时选择表面活性物质给药策略。

要点

  • 矫正年龄2岁时出院后死亡或严重残疾:IN-SUR-E组13例(20.3%)vs IN-REC-SUR-E组10例(13.7%),P=0.36,无显著差异。
  • IN-REC-SUR-E组与IN-SUR-E组相比,残疾、脑瘫、认知障碍发生率均无显著差异。
  • 两组体格测量指标(体重、身长、头围)无显著差异。
  • 两组反复呼吸道感染发生率及因呼吸原因住院率无显著差异。
  • 共137例极早产儿完成2年随访(IN-SUR-E组64例,IN-REC-SUR-E组73例),中位胎龄26.5(IQR 25.3-27.5)周,女性75例(54.7%)。

适用人群与场景

  • 胎龄24 0/7至27 6/7周、生后24小时内达到持续气道正压通气失败标准的自主呼吸极早产儿,来自意大利35个三级新生儿重症监护病房。

研究设计与关键结果

  • 研究类型:多中心随机临床试验的随访研究,纳入2015至2018年意大利35个三级新生儿重症监护病房的极早产儿,随机1:1接受IN-REC-SUR-E或IN-SUR-E,随访至矫正年龄2岁。
  • 共137例完成随访:IN-SUR-E组64例,IN-REC-SUR-E组73例;中位胎龄26.5(IQR 25.3-27.5)周,女性75例(54.7%)。
  • 主要终点(出院后死亡或严重残疾):IN-SUR-E组13例(20.3%)vs IN-REC-SUR-E组10例(13.7%),P=0.36,无显著差异。
  • 次要终点:IN-REC-SUR-E组与IN-SUR-E组相比,残疾、脑瘫、认知障碍发生率均无显著差异。
  • 体格测量指标(体重、身长、头围)两组无显著差异。
  • 反复呼吸道感染发生率及因呼吸原因住院率两组无显著差异。

证据类型、等级与局限

  • 证据类型:多中心随机临床试验的随访研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现可帮助临床医生在考虑长期结局时选择表面活性物质给药策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A multicenter randomized clinical trial (RCT) showed a lung recruitment maneuver using high-frequency oscillatory ventilation just before surfactant administration (ie, intubate-recruit-surfactant-extubate [IN-REC-SUR-E]) improved the efficacy of treatment compared with the standard intubate-surfactant-extubate (IN-SUR-E) technique without increasing the risk of adverse neonatal outcomes.

OBJECTIVE: To examine follow-up outcomes at corrected postnatal age (cPNA) 2 years of preterm infants previously enrolled in an RCT and treated with IN-REC-SUR-E or IN-SUR-E in 35 tertiary neonatal intensive care units.

DESIGN, SETTING, AND PARTICIPANTS: This was a follow-up study of infants recruited into the primary RCT from 2015 to 2018 at 35 tertiary neonatal intensive care units (NICUs) in Italy. Follow-up examinations included neurodevelopmental, growth, and respiratory outcomes of these children at cPNA 2 years. Participants included spontaneously breathing extremely preterm neonates (24 0/7 to 27 6/7 weeks' gestation) reaching failure criteria for continuous positive airway pressure within the first 24 hours of life. Data were analyzed from April 2023 to January 2024.

INTERVENTION: Infants were randomly assigned (1:1) to IN-REC-SUR-E or IN-SUR-E and then followed up.

MAIN OUTCOMES AND MEASURES: The primary outcome was the occurrence of death after discharge or major disability at cPNA 2 years. Secondary outcomes were neurodevelopmental outcomes (major disability, cerebral palsy, cognitive impairment, visual deficit, or auditory deficit), anthropometric measurements (weight, length, and head circumference), and recurrent respiratory infections and hospitalizations because of respiratory causes at 2y cPNA.

RESULTS: A total of 137 extremely preterm infants (median [IQR] gestational age, 26.5 [25.3-27.5] weeks and 75 [54.7%] female), initially enrolled in the original RCT, were followed up at cPNA 2 years, including 64 infants in the IN-SUR-E group and 73 infants in the IN-REC-SUR-E group. There were no significant differences in the occurrence of death after discharge or major disability at cPNA 2 years (IN-SUR-E: 13 children [20.3%] vs IN-REC-SUR-E: 10 children [13.7%]; P = .36). There were no significant differences in incidence of disability, cerebral palsy, or cognitive impairment in the IN-REC-SUR-E group compared with the IN-SUR-E group. There were no significant differences in anthropometric measurements (weight, length, and head circumference) between groups. There were no significant differences in the incidence of recurrent respiratory infections or in hospitalizations because of respiratory causes between groups.

CONCLUSIONS AND RELEVANCE: In this RCT of lung recruitment before surfactant vs standard care there were no significant differences between the 2 groups in death, neurodevelopmental outcomes, anthropometric measurements, or recurrent respiratory infections at the 2-year follow-up. These findings can aid clinicians in decision-making for the best strategy to administer surfactant, considering long-term outcomes.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Gallini F, De Rose DU, Iuliano R, et al. Lung Recruitment Before Surfactant Administration in Extremely Preterm Neonates: 2-Year Follow-Up of a Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 39320892. doi:10.1001/jamanetworkopen.2024.35347

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。